complete list of glp 1 drugs approved and pending GLP-1 medications The list of conditions for
Description
PMID: 34 KaracabeyliDLacailleD
But there's a catchand one unlikely to surprise anyone familiar with the U.S

The other peptides I-M-150845, I-M-150846, and I-M-150847 were designed in-house, outsourced for chemical synthesis and purification to GL Biochem China

Breast Cancer: A 3047% Risk Reduction Among the most clinically significant findings was a real-world cohort study presented at ASCO 2026, which reported that women with Type 2 diabetes or obesity using GLP-1 receptor agonists experienced a 30 to 47% reduction in breast cancer risk compared to non-users

Understanding long-term weight loss sustainability clarifies what these patterns mean

Dysesthesia occurred in 8.8% and 20.9% (9 mg and 12 mg, respectively) of patients treated with retatrutide, compared to 0.7% with placebo
